Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,947

Document Document Title
WO/2022/165663A1
Disclosed in the present application is a method for preparing glycolic acid by hydrolysis of alkoxyacetate. The method comprises: enabling a raw material comprising alkoxyacetate and water to react in the presence of an acidic molecular...  
WO/2022/165662A1
Disclosed is a method for preparing glycolic acid and methyl glycolate by hydrolysis of methyl methoxyacetate and methoxyacetic acid. The method comprises: contacting a raw material comprising methyl methoxyacetate, methoxyacetic acid, a...  
WO/2022/169363A1
The invention provides a method for the extraction of an organic acid (10) from a mixture (110), the method comprising: an extraction stage comprising providing the mixture (110) to a sorbent (150); an elution stage comprising passing an...  
WO/2022/154537A1
The present invention relates to a process of recovering 3-hydroxypropionic acid, comprising the steps of: forming crystals of 3-hydroxypropionate in a concentrated solution including 300 g/L or more of 3-hydroxypropionic acid in the pre...  
WO/2022/150917A1
The invention relates to crystalline forms of Alpha-1062 gluconate (scheme I: (I)). In one aspect, the invention relates to a crystalline solid form of Alpha-1062 gluconate (Form A), wherein said crystalline form has prominent peaks at 3...  
WO/2022/149161A1
The present application relates to a process for preparation of Bempedoic acid of formula (I) or its pharmaceutically acceptable salts thereof. The present application also relates to a novel intermediates of formula (II) and formula (II...  
WO/2022/141739A1
A method for producing α-calcium sulfate hemihydrate whiskers by using a fermentation liquor for producing lactic acid by means of a calcium salt method as a raw material, and synchronously recovering a lactic acid monomer. The method c...  
WO/2022/133719A1
Relates to a method for producing glycolic acid by selectively hydrogenating glyoxylic acid using a catalyst comprising at least one transition metal element, the glycolic acid produced, as well as the uses thereof.  
WO/2022/138670A1
Provided are a compound, polymer, composition, film-forming composition, pattern formation method, method for forming insulating films, and compound production method, that yield a resist that exhibits excellent exposure sensitivity. T...  
WO/2022/135433A1
A method for producing glycolic acid by selectively hydrogenating glyoxylic acid using a catalyst comprising at least one transition metal element, the glycolic acid produced, as well as the uses thereof.  
WO/2022/136346A1
The invention relates to ferulic acid granules and the production method thereof. The invention is suitable for use in paritcular in the fields of food, cosmetics and flavours.  
WO/2022/138659A1
Provided is a method for producing a fluorovinyl ether compound capable of suppressing the generation of by-products. The method for producing a fluorovinyl ether compound of the present invention is a method for producing a fluoroviny...  
WO/2022/131073A1
Provided is a hydroxyalkanoic acid crystal production method characterized by including a step for freeze-drying a solution containing hydroxyalkanoic acid, and (1) the content of an R-body being 95-100 mass% or more, or (2) the content ...  
WO/2022/115971A1
Disclosed are methods for separating, recovering, and purifying CBGA, CBDVA, THCVA, CBCVA, and CBCA from dewatered and desolventized crude complex extracts or mixtures of metabolites, cannabinoids, and cannabis phytochemicals. The method...  
WO/2022/110821A1
Disclosed are a carboxylic acid compound as represented by formula I, a preparation method therefor and the use thereof. When the carboxylic acid compound is used as an extraction agent for the extraction and separation of metal ions, th...  
WO/2022/115326A1
Described herein are methods of making the PPARδ agonist compound (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1- yl)phenyl)allyl)oxy)-2-methylphenoxy)acetic acid, including salt forms thereof.  
WO/2022/106893A1
The present invention is directed to Form A of monohydrate of calcium oxybate, a pharmaceutically acceptable composition thereof, its method of making, and use thereof.  
WO/2022/107889A1
Provided is a fluoropolymer comprising a monomer (I) represented by general formula (I), wherein the content of a polymerization unit (I) based on the monomer (I) is 40 mol% with respect to the total polymerization units constituting the...  
WO/2022/104245A2
Provided herein is a compound which is particularly suitable for use as a cannabinoid, as an emulsifier for a cannabinoid, in a formulation comprising the compound and in a method of treatment using the compound. The compound is defined ...  
WO/2022/098881A1
Disclosed are compounds and methods to enhance the resolution of inflammation and inflammatory diseases comprising novel compounds derived from conjugated specialized pro-resolving lipid mediators (SPMs). These compounds are useful in pr...  
WO/2022/099018A1
The present invention relates to processes of preparing PD-1/PD-L1 inhibitor (R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)meth yl)-1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)b enzo[d]oxazol-5-yl)methyl)pyrrolidine-...  
WO/2022/080905A1
The present specification relates to an apparatus for vaporizing lactic acid. According to a method and an apparatus for vaporizing lactic acid, of the present invention, the quantity of lactic acid oligomers can be reduced within a shor...  
WO/2022/077851A1
The present invention discloses a 1,4-dihydropyridine chiral hybrid hydrogenation reagent, a preparation method and an application thereof. The 1,4-dihydropyridine chiral hybrid hydrogenation reagent has a structure represented by formul...  
WO/2022/069651A1
The present invention relates to a method for purifying a liquid medium comprising ferulic acid, a solvent and at least one impurity, the method comprising a step (a) of bringing the liquid medium into contact with a first complexing age...  
WO/2022/065090A1
A radiation-sensitive resin composition which exhibits sufficient sensitivity, LWR performance and CDU performance, a pattern forming method and an onium salt compound are provided. This radiation-sensitive resin composition comprises an...  
WO/2022/064351A1
Process for producing levulinic acid, which includes a step of catalytic conversion of a pentose (in particular xylose or arabinose) into furfural in an organic solvent having a boiling temperature from 600C to 220°C, followed by a step...  
WO/2022/052936A1
Provided are the aryl propionic acid derivative shown in formula (I), pharmaceutical composition, and method for preparation thereof and application thereof. The aryl propionic acid derivative described has good half-life, pharmacokineti...  
WO/2022/049387A1
A process for refining a crude ethylene glycol stream comprising monoethylene glycol and at least one acid contaminant is disclosed. The process comprises reacting the acid contaminant with the monoethylene glycol in at least one reactio...  
WO/2022/038098A1
The present invention relates to a process for the preparation of phenyl ketones and the preparation of phenoxyphenyl derivatives.  
WO/2022/039144A1
A compound represented by the formula, a method for producing the same, and the use of the compound. Ring Ar1 and ring Ar2 represent an aromatic ring represented by a specific formula or a condensed ring thereof, and R1 and R2 represent ...  
WO/2022/033563A1
The present application relates to a JAK inhibitor compound and use thereof. Specifically, disclosed in the present application is a compound in a solid form as shown in formula (I), or an isotopically labeled compound thereof, or an opt...  
WO/2022/028317A1
Provided herein are novel compounds (e.g., Formula I), pharmaceutical compositions, and methods of using related to GPR40. The compounds herein are typically GPR40 agonists, which can be used for treating a variety of disorders, conditio...  
WO/2022/029357A1
The present invention relates to a compound 1 or 2 or a composition comprising same. The present invention also relates to a method for producing a compound 1 or 2, and the use thereof to detect GHB in drinks and urine. The invention als...  
WO/2022/027945A1
The present invention relates to a fluorine-containing polymer for a photoresist, a top anti-reflection film composition comprising the fluorine-containing polymer, and an application of the fluorine-containing polymer in a photoresist. ...  
WO/2022/029358A1
The present invention relates to a compound 1 or 2 or a composition comprising same. The invention also relates to a method for obtaining compound 1 or 2, and to the use of the compounds to detect GHB in beverages. The invention also inc...  
WO/2022/028821A1
The present invention pertains to a method for preparing 3-hydroxy-3-methylbutyric acid (HMB) or salts thereof from tert-butanol and carbon monoxide, wherein tert-butanol is reacted in an aqueous mixture with carbon monoxide under electr...  
WO/2022/021506A1
The present invention relates to the technical field of catalysis. Disclosed are a preparation of an ultrathin porous carbon nitride nano-photocatalyst and applications thereof in photocatalytically oxidizing fructose to synthesize lacti...  
WO/2022/025110A1
Provided is a means for producing an α-hydroxy carboxylic acid composition purified at high yield and high purity. This method for producing an α-hydroxy carboxylic acid composition involves distilling a mixed solution containing α-hy...  
WO/2022/014395A1
This refining method involves crystallizing a compound that has at least one crystalline form, wherein: a specific infrared wavelength, at which a specific crystalline form precipitates from a solution obtained by dissolving the compound...  
WO/2022/014884A1
The present invention relates to a method for manufacturing liquid calcium citrate (C12H14CaO14) or mono calcium citrate powder by using shells and application thereof and, more specifically, to a method for manufacturing liquid calcium ...  
WO/2022/014397A1
This refining method is for crystallizing a compound having at least one crystal form. A specific infrared wavelength and a specific concentration at which a specific crystal form precipitates from a solution in which the compound is dis...  
WO/2022/014396A1
A purification method according to the present invention is a purification method that brings about the crystallization of a compound that has at least one crystalline form. A prescribed infrared wavelength and prescribed temperature at ...  
WO/2022/000881A1
Provided are a carboxylic acid compound of formula I, and a preparation method therefor and application thereof. When being applied to the extraction and separation of metal ions, the carboxylic acid compound can achieve a high separatio...  
WO/2021/261467A1
Provided are: a powder of a pure disilver hydrogen citrate-containing composition in powder form having excellent solubility; and a method for obtaining said disilver hydrogen citrate-containing composition easily and highly efficiently....  
WO/2021/255180A1
The present invention relates to 2-aminoethanol, piperazine and L- lysine salts of Bempedoic acid and processes for the preparation thereof.  
WO/2021/248271A1
Citric acid is purified to remove metal ions through a two-step filtration process. A first filter is used to perform a first filtration, then a second filter is used to perform a second filtration on citric acid solution that has been s...  
WO/2021/250967A1
The purpose of the present disclosure is to provide an ink for inkjet printers, said ink achieving both good visibility of print dots after being heated and high dissolution stability. For the purpose of achieving the above, an ink for i...  
WO/2021/245440A1
The present invention relates to a novel liquid-liquid extraction process of a bio-oil obtained by an improved thermochemical process. This extraction process gives rise to two distinct phases: an organic phase, with bio-oil of energetic...  
WO/2021/236395A1
CB-0406 choline salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.  
WO/2021/234694A1
Lipid particles for nucleic acid delivery and clinical applications of same are provided. Accordingly there is provided a lipid particle comprising a cationic lipid encapsulating a nucleic acid sequence, wherein said nucleic acid sequenc...  

Matches 1 - 50 out of 7,947